IBRX
Price
$2.32
Change
-$0.02 (-0.85%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
2.2B
70 days until earnings call
RXRX
Price
$4.86
Change
-$0.03 (-0.61%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
2.11B
68 days until earnings call
Interact to see
Advertisement

IBRX vs RXRX

Header iconIBRX vs RXRX Comparison
Open Charts IBRX vs RXRXBanner chart's image
ImmunityBio
Price$2.32
Change-$0.02 (-0.85%)
Volume$48.24K
Capitalization2.2B
Recursion Pharmaceuticals
Price$4.86
Change-$0.03 (-0.61%)
Volume$122.64K
Capitalization2.11B
IBRX vs RXRX Comparison Chart in %
Loading...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IBRX vs. RXRX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBRX is a Buy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (IBRX: $2.33 vs. RXRX: $4.86)
Brand notoriety: IBRX and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBRX: 80% vs. RXRX: 50%
Market capitalization -- IBRX: $2.2B vs. RXRX: $2.11B
IBRX [@Biotechnology] is valued at $2.2B. RXRX’s [@Biotechnology] market capitalization is $2.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBRX’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • IBRX’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than IBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBRX’s TA Score shows that 2 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • IBRX’s TA Score: 2 bullish, 7 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than IBRX.

Price Growth

IBRX (@Biotechnology) experienced а +4.02% price change this week, while RXRX (@Biotechnology) price change was +1.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

IBRX is expected to report earnings on Nov 07, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.2B) and RXRX($2.11B) have the same market capitalization . IBRX YTD gains are higher at: -8.984 vs. RXRX (-28.033). IBRX has higher annual earnings (EBITDA): -237.93M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. IBRX (154M). RXRX has less debt than IBRX: RXRX (88.1M) vs IBRX (535M). RXRX has higher revenues than IBRX: RXRX (64.5M) vs IBRX (56.6M).
IBRXRXRXIBRX / RXRX
Capitalization2.2B2.11B104%
EBITDA-237.93M-583.64M41%
Gain YTD-8.984-28.03332%
P/E RatioN/AN/A-
Revenue56.6M64.5M88%
Total Cash154M525M29%
Total Debt535M88.1M607%
FUNDAMENTALS RATINGS
IBRX: Fundamental Ratings
IBRX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IBRXRXRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
86%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLRSX13.46N/A
N/A
NYLI Winslow Large Cap Growth Class R6
IEOPX13.21N/A
N/A
Voya Large Cap Growth Port A
NWKAX15.29N/A
N/A
Nationwide Geneva Mid Cap Gr R6
HWVAX12.64N/A
N/A
Hotchkis & Wiley Sm Cp Divers Val A
GFGEX12.68N/A
N/A
Guardian Fundamental Glb Eq instl